Surgery
Conditions
Interventions
Mitral valve replacement with TV repair
Mitral valve replacement
Sponsors
Al Azhar University hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with moderate functional TR secondary to rheumatic mitral valve pathology
Exclusion criteria
Exclusion criteria: patients with organic TV involvement, regardless of aetiology, such as congenital defects, trauma, infective endocarditis, or carcinoid syndrome, TV stenosis, undergoing concomitant cardiac surgical procedures other than mitral valve replacement, redo-operation, and low EF< 50%.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative Cardiac Function Improvement assessed by Changes in tricuspid regurgitation (TR) severity post-surgery (e.g., by echocardiography). Assessment of right ventricular function (e.g., TAPSE, RV size). and assessment of Left ventricular function if affected secondarily. Overall Surgical Outcome: In-hospital mortality or 30-day mortality and Success of mitral valve replacement and impact on tricuspid regurgitation. | — |
Secondary
| Measure | Time frame |
|---|---|
| Functional Status Improvement: Change in New York Heart Association (NYHA) functional class and Improvement in symptoms such as fatigue, dyspnea, and peripheral edema. Echocardiographic Parameters Over Time: Incidence of arrhythmias, renal dysfunction, ICU stay, and reoperation.Length of hospital stay. | — |
Countries
Egypt
Contacts
Public ContactAdel Khalaf
Professor of Cardiothoracic surgery Al Azhar University Assiut
Outcome results
None listed